{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:16:34Z","timestamp":1758816994535},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:p>Thrombocytopenia presenting during early childhood is most commonly diagnosed as immune\/idiopathic thrombocytopenic purpura (ITP), where the antibody-mediated destruction of thrombocytes is often transient. If treatment is indicated, the majority of patients respond to immune-modulation by intravenous immunoglobulin G infusion or systemic corticosteroids. Differential diagnoses to childhood ITP includes thrombocytopenia due to infections, drugs, rheumatologic conditions, immune dysregulation, and inherited bone marrow failures, for example, congenital amegakaryocytic thrombocytopenia. Isolated thrombocytopenia in an otherwise healthy appearing child that recurs after therapy and\/or persists suggest a differential diagnosis rather than ITP. We present a case of symptomatic thrombocytopenia in a 2-year-old girl associated with adenosine deaminase deficiency.<\/jats:p>","DOI":"10.1097\/mph.0000000000001132","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T16:17:18Z","timestamp":1522858638000},"page":"155-157","source":"Crossref","is-referenced-by-count":17,"title":["\u201cImmune\u201d Thrombocytopenia as Key Feature of a Novel ADA2 Deficiency Variant: Implication on Differential Diagnostics of ITP in Children"],"prefix":"10.1097","volume":"41","author":[{"given":"Mikael","family":"Sundin","sequence":"first","affiliation":[{"name":"The Astrid Lindgren Children\u2019s Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"Marits","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Karolinska University Hospital, and Karolinska Institute, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Nierkens","sequence":"additional","affiliation":[{"name":"Laboratory of Translational Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonios G.A.","family":"Kolios","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, University Hospital Zurich, Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakob","family":"Nilsson","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Karolinska University Hospital, and Karolinska Institute, Stockholm, Sweden"},{"name":"Department of Clinical Immunology, University Hospital Zurich, Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.clim.2014.05.010","article-title":"Evaluation of T and B lymphocyte function in clinical practice using a flow cytometry based proliferation assay","volume":"153","author":"Marits","year":"2014","journal-title":"Clin Immunol"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa1307361","article-title":"Early-onset stroke and vasculopathy associated with mutations in ADA2","volume":"370","author":"Zhou","year":"2014","journal-title":"N Engl J Med"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/rheumatology\/kev439","article-title":"Phenotypic variability in patients with ADA2 deficiency due to identical homozygous R169Q mutations","volume":"55","author":"Van Montfrans","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/bioinformatics\/btu703","article-title":"DANN: a deep learning approach for annotating the pathogenicity of genetic variants","volume":"31","author":"Quang","year":"2015","journal-title":"Bioinformatics"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"283.e5","DOI":"10.1016\/j.jaci.2014.10.010","article-title":"Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency","volume":"135","author":"Van Eyck","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00296-017-3740-3","article-title":"Clinical, imaging and genotypical features of three deceased and five surviving cases with ADA2 deficiency","volume":"38","author":"Sahin","year":"2017","journal-title":"Rheumatol Int"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1002\/art.39699","article-title":"Deficiency of adenosine deaminase type 2: a description of phenotype and genotype in fifteen cases","volume":"68","author":"Nanthapisal","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/art.40147","article-title":"Screening of 181 patients with antibody deficiency for deficiency of adenosine deaminase 2 sheds new light on the disease in adulthood","volume":"69","author":"Schepp","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.scr.2011.04.001","article-title":"Mesenchymal stromal cells up-regulate CD39 and increase adenosine production to suppress activated T-lymphocytes","volume":"7","author":"Saldanha-Araujo","year":"2011","journal-title":"Stem Cell Res"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/nrc3613","article-title":"Immunity, inflammation and cancer: a leading role for adenosine","volume":"13","author":"Antonioli","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"R11-20230918","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00018-016-2357-0","article-title":"Human adenosine deaminases ADA1 and ADA2 bind to different subsets of immune cells","volume":"74","author":"Kaljas","year":"2017","journal-title":"Cell Mol Life Sci"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00043426-201903000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T04:45:23Z","timestamp":1695012323000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201903000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000001132","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}